Tearsheet

Longevity Health (XAGE)

Market Price (9/17/2025): $2.29 | Market Cap: $2.8 Mil
Sector: Consumer Staples | Industry: Household Products

Longevity Health (XAGE)

Market Price (9/17/2025): $2.29
Market Cap: $2.8 Mil
Sector: Consumer Staples
Industry: Household Products

Investment Highlights

0	Cash is significant % of market cap Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -84%	Weak multi-year price returns 2Y Excs Rtn is -147%, 3Y Excs Rtn is -162%	Not profitable at operating income level Op Inc LTMOperating Income, Last Twelve Months is -5.8 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -551%
1	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 8439%		Not cash flow generative CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -358%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -358%
2	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -25%		Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -516%
3			High stock price volatility Vol 12M is 2139%

0	Cash is significant % of market cap Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -84%
1	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 8439%
2	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -25%
3	Weak multi-year price returns 2Y Excs Rtn is -147%, 3Y Excs Rtn is -162%
4	Not profitable at operating income level Op Inc LTMOperating Income, Last Twelve Months is -5.8 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -551%
5	Not cash flow generative CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -358%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -358%
6	Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -516%
7	High stock price volatility Vol 12M is 2139%

Market Valuation

	9/17/25	2024	2023	2022	2021
Share Price CYE	$2.29	$8.37	$114.30	$297.52	$288.60
Market Cap CYE ($ Mil)	2.8	5.8	88.0	190.8	349.2
Total Debt ($ Mil)	0.4	0.6	2.1	3.7	9.7
Total Cash ($ Mil)	1.6	0.2	2.9	0.1	0.0
Enterprise Value ($ Mil)	1.6	6.4	90.1	194.5	358.9
Valuation Ratios
P/S TTM	2.6	4.0	0.0	0.0	0.0
P/EBIT TTM	-0.4	-0.0	-0.1	-1.2	-1.6
P/E TTM	-0.4	-0.0	-0.1	-0.7	-0.9
Sector Ratios
P/S TTM (Sector)	0.9	0.9	0.9	0.9	1.6
P/EBIT TTM (Sector)	8.3	8.9	10.0	9.4	11.6
P/E TTM (Sector)	12.5	12.1	14.0	12.0	16.2

	9/17/25	2024	2023
Share Price CYE	$2.29	$8.37	$114.30
Market Cap CYE ($ Mil)	2.8	5.8	88.0
Total Debt ($ Mil)	0.4	0.6	2.1
Total Cash ($ Mil)	1.6	0.2	2.9
Enterprise Value ($ Mil)	1.6	6.4	90.1
Valuation Ratios
P/S TTM	2.6	4.0	0.0
P/EBIT TTM	-0.4	-0.0	-0.1
P/E TTM	-0.4	-0.0	-0.1
Sector Ratios
P/S TTM (Sector)	0.9	0.9	0.9
P/EBIT TTM (Sector)	8.3	8.9	10.0
P/E TTM (Sector)	12.5	12.1	14.0

Stock Price
Market Cap

Stock Price Chart

Return (1Y):

Market Cap Chart

Business Description

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania. Show more

Price Returns Compared

Expand for Detailed View

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
XAGE Return	-	-	3%	-62%	-93%	-72%	-99%
Peers Return	2%	28%	-12%	25%	-8%	6%	43%
S&P 500 Return	16%	27%	-19%	24%	23%	12%	104%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: IPAR, CENT, LRLCY, PORBF, RPHCF.
[3] 2025 data is for the year up to 9/16/2025 (YTD)

Better Bets than Longevity Health (XAGE)

	XAGE	Better Performance than XAGE
Metric	Value	Industry (Household Products)
Rev Chg LTM	8438.7%
Op Mgn LTM	-550.6%	UL (14.4%), CL (21.7%), KMB (16.7%), CHD (17.8%), CLX (16.7%)
CFO/Rev LTM	-357.8%	UL (12.4%), CL (19.6%), KMB (15.2%), CHD (17.7%), CLX (13.8%)
FCF/Rev LTM	-357.8%	UL (12.4%), CL (16.9%), KMB (11.1%), CHD (15.3%), CLX (10.7%)
Total Yield	-512.0%	UL (3.8%), CL (7.1%), KMB (9.8%), CHD (3.0%), CLX (7.2%)

	XAGE	Better Performance than XAGE
Metric	Value	Sector (Consumer Staples)
Rev Chg LTM	8438.7%
Op Mgn LTM	-550.6%	WMT (4.2%), COST (3.8%), PG (24.3%), KO (30.6%), PM (36.4%)
CFO/Rev LTM	-357.8%	WMT (5.5%), COST (4.6%), PG (21.1%), KO (2.8%), PM (26.6%)
FCF/Rev LTM	-357.8%	WMT (2.0%), COST (2.7%), PG (16.7%), KO (-1.5%), PM (23.0%)
Total Yield	-512.0%	WMT (3.4%), COST (2.1%), PG (4.3%), KO (7.2%), PM (6.5%)

	XAGE	Better Performance than XAGE
Metric	Value	All Other Sectors
Rev Chg LTM	8438.7%	SPRY (22367.8%), GERN (11877.2%), CRMD (14970.3%), KROS (85820.3%), GXAI (72158.5%)
Op Mgn LTM	-550.6%	NVDA (58.1%), MSFT (45.6%), AAPL (31.9%), GOOGL (32.7%), AMZN (11.4%)
CFO/Rev LTM	-357.8%	NVDA (46.6%), MSFT (48.3%), AAPL (26.6%), GOOGL (36.0%), AMZN (18.1%)
FCF/Rev LTM	-357.8%	NVDA (43.6%), MSFT (25.4%), AAPL (23.5%), GOOGL (18.0%), AMZN (2.0%)
Total Yield	-512.0%	NVDA (2.1%), MSFT (3.3%), AAPL (3.2%), GOOGL (4.1%), AMZN (2.8%)

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	FGI	FGI Industries	139.3%	145.2%
2	CODX	Co-Diagnostics	80.8%	-14.8%
3	CNFR	Conifer	55.5%	50.4%
4	BGI	Birks	55.4%	-18.1%
5	FLUX	Flux Power	52.2%	99.4%
6	BOXL	Boxlight	45.7%	32.1%
7	LVRO	Lavoro	45.5%	-57.4%
8	NFE	New Fortress Energy	44.9%	-86.8%
9	WBTN	Webtoon Entertainment	39.0%	53.2%
10	HCWC	Healthy Choice Wellness	37.5%	-34.7%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	REX	REX American Resources	-50.1%	46.1%
2	XAGE	Longevity Health	-39.3%	-86.1%
3	BNGO	Bionano Genomics	-35.7%	-89.7%
4	IHT	InnSuites Hospitality Trust	-30.7%	7.3%
5	LUD	Luda Technology	-28.6%
6	NAOV	NanoVibronix	-28.5%	-88.2%
7	GDC	GD Culture	-28.2%	269.8%
8	ASST	Strive	-28.0%	813.4%
9	BIAF	bioAffinity Technologies	-25.5%	-71.3%
10	FAAS	DigiAsia	-23.9%	-87.2%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	BDSX	Biodesix	1313.2%	-78.6%
2	CLSD	Clearside Biomedical	954.0%	-74.9%
3	SDOT	Sadot	624.1%	-79.4%
4	WLDS	Wearable Devices	498.0%	-30.0%
5	CHEK	Check-Cap	285.6%	154.6%
6	ATCH	AtlasClear	275.9%	-91.0%
7	HSDT	Helius Medical Technologies	262.5%	-95.6%
8	OPI	Office Properties Income Trust	261.7%	-13.4%
9	FGI	FGI Industries	156.8%	145.2%
10	AIRE	ReAlpha Tech	154.0%	-56.1%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	NAKA	Kindly MD	-81.4%
2	ATYR	aTyr Pharma	-79.7%	-70.2%
3	LGCL	Lucas GC	-73.6%	-77.1%
4	EPSM	Epsium Enterprise	-70.1%
5	BNGO	Bionano Genomics	-59.4%	-89.7%
6	FAAS	DigiAsia	-58.5%	-87.2%
7	QMMM	QMMM	-57.5%	6775.0%
8	VCIG	VCI Global	-56.9%	-99.1%
9	YYGH	YY	-56.6%	-78.5%
10	XAGE	Longevity Health	-55.5%	-86.1%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PMI	Picard Medical	11963.5%	11963.5%
2	GIBO	GIBO	9734.4%
3	CHSN	Chanson International	7565.0%	-99.3%
4	LNZA	LanzaTech Global	7287.5%	-86.0%
5	QMMM	QMMM	3031.7%	6775.0%
6	OESX	Orion Energy Systems	1497.9%	22.9%
7	CURX	Curanex Pharmaceuticals	1401.6%	1401.6%
8	ENTO	Entero Therapeutics	565.6%	117.6%
9	PTNM	Pitanium	553.2%
10	WLDS	Wearable Devices	449.5%	-30.0%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	CJET	Chijet Motor	-92.2%	-95.0%
2	STFS	Star Fashion Culture	-92.2%	-97.8%
3	ELPW	Elong Power	-91.6%	-76.7%
4	NXTT	Next Technology	-89.6%	-95.1%
5	NAKA	Kindly MD	-89.0%
6	BINI	Bollinger Innovations	-88.9%	-100.0%
7	JEM	707 Cayman	-88.4%	-98.2%
8	YAAS	Youxin Technology	-82.5%	-98.3%
9	NEON	Neonode	-82.0%	-50.2%
10	NVNO	enVVeno Medical	-81.5%	-69.8%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	FGI	FGI Industries	139.3%	145.2%
2	CODX	Co-Diagnostics	80.8%	-14.8%
3	CNFR	Conifer	55.5%	50.4%
4	BGI	Birks	55.4%	-18.1%
5	FLUX	Flux Power	52.2%	99.4%
6	BOXL	Boxlight	45.7%	32.1%
7	LVRO	Lavoro	45.5%	-57.4%
8	NFE	New Fortress Energy	44.9%	-86.8%
9	WBTN	Webtoon Entertainment	39.0%	53.2%
10	HCWC	Healthy Choice Wellness	37.5%	-34.7%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	REX	REX American Resources	-50.1%	46.1%
2	XAGE	Longevity Health	-39.3%	-86.1%
3	BNGO	Bionano Genomics	-35.7%	-89.7%
4	IHT	InnSuites Hospitality Trust	-30.7%	7.3%
5	LUD	Luda Technology	-28.6%
6	NAOV	NanoVibronix	-28.5%	-88.2%
7	GDC	GD Culture	-28.2%	269.8%
8	ASST	Strive	-28.0%	813.4%
9	BIAF	bioAffinity Technologies	-25.5%	-71.3%
10	FAAS	DigiAsia	-23.9%	-87.2%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	BDSX	Biodesix	1313.2%	-78.6%
2	CLSD	Clearside Biomedical	954.0%	-74.9%
3	SDOT	Sadot	624.1%	-79.4%
4	WLDS	Wearable Devices	498.0%	-30.0%
5	CHEK	Check-Cap	285.6%	154.6%
6	ATCH	AtlasClear	275.9%	-91.0%
7	HSDT	Helius Medical Technologies	262.5%	-95.6%
8	OPI	Office Properties Income Trust	261.7%	-13.4%
9	FGI	FGI Industries	156.8%	145.2%
10	AIRE	ReAlpha Tech	154.0%	-56.1%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	NAKA	Kindly MD	-81.4%
2	ATYR	aTyr Pharma	-79.7%	-70.2%
3	LGCL	Lucas GC	-73.6%	-77.1%
4	EPSM	Epsium Enterprise	-70.1%
5	BNGO	Bionano Genomics	-59.4%	-89.7%
6	FAAS	DigiAsia	-58.5%	-87.2%
7	QMMM	QMMM	-57.5%	6775.0%
8	VCIG	VCI Global	-56.9%	-99.1%
9	YYGH	YY	-56.6%	-78.5%
10	XAGE	Longevity Health	-55.5%	-86.1%

Peer Comparisons for Longevity Health

Financials

	XAGE	IPAR	CENT	LRLCY	PORBF	RPHCF	Median
Name	Longevit.	Interpar.	Central .	L'Oreal	Pola Orb.	Rohto Ph.
Mkt Price	1.16	105.00	35.58	89.26	-	-	62.42
Mkt Cap	0.0	3.4	2.2	248.9	-	-	2.8
Rev LTM	1	1,459	3,120	-	-	-	1,459
Op Inc LTM	-6	280	224	-	-	-	224
FCF LTM	-4	158	312	-	-	-	158
FCF 3Y Avg	-6	75	277	-	-	-	75
CFO LTM	-4	219	353	-	-	-	219
CFO 3Y Avg	-6	133	325	-	-	-	133

Growth & Margins

	XAGE	IPAR	CENT	LRLCY	PORBF	RPHCF	Median
Name	Longevit.	Interpar.	Central .	L'Oreal	Pola Orb.	Rohto Ph.
Rev Chg LTM	8,438.7%	7.0%	-4.9%	-	-	-	7.0%
Rev Chg 3Y Avg	-	14.9%	-2.5%	-	-	-	6.2%
Rev Chg Q	3,987.8%	-2.4%	-3.6%	-	-	-	-2.4%
QoQ Delta Rev Chg LTM	87.6%	-0.6%	-1.1%	-	-	-	-0.6%
Op Mgn LTM	-550.6%	19.2%	7.2%	-	-	-	7.2%
Op Mgn 3Y Avg	-	18.9%	6.9%	-	-	-	12.9%
QoQ Delta Op Mgn LTM	363.5%	-0.3%	0.7%	-	-	-	0.7%
CFO/Rev LTM	-357.8%	15.0%	11.3%	-	-	-	11.3%
CFO/Rev 3Y Avg	-	9.7%	10.1%	-	-	-	9.9%
FCF/Rev LTM	-357.8%	10.9%	10.0%	-	-	-	10.0%
FCF/Rev 3Y Avg	-	5.4%	8.6%	-	-	-	7.0%

Valuation

	XAGE	IPAR	CENT	LRLCY	PORBF	RPHCF	Median
Name	Longevit.	Interpar.	Central .	L'Oreal	Pola Orb.	Rohto Ph.
Mkt Cap	0.0	3.4	2.2	248.9	-	-	2.8
P/S	1.3	2.3	0.7	-	-	-	1.3
P/EBIT	-0.2	12.3	9.1	-	-	-	9.1
P/E	-0.2	20.9	15.9	-	-	-	15.9
P/CFO	-0.4	15.4	6.2	-	-	-	6.2
Total Yield	-512.0%	7.7%	6.3%	-	-	-	6.3%
Dividend Yield	0.0%	2.9%	0.0%	0.0%	-	-	0.0%
FCF Yield 3Y Avg	-410.7%	1.8%	12.3%	-	-	-	1.8%
D/E	0.3	0.1	0.7	0.0	-	-	0.2
Net D/E	-0.8	0.0	0.3	-0.0	-	-	0.0

Returns

	XAGE	IPAR	CENT	LRLCY	PORBF	RPHCF	Median
Name	Longevit.	Interpar.	Central .	L'Oreal	Pola Orb.	Rohto Ph.
1M Rtn	-54.4%	-6.2%	-0.6%	-3.1%	-	-	-4.6%
3M Rtn	-48.8%	-21.8%	3.9%	5.9%	-	-	-9.0%
6M Rtn	-82.6%	-12.5%	-0.7%	15.4%	-	-	-6.6%
12M Rtn	-91.0%	-9.6%	-7.3%	11.2%	-	-	-8.5%
3Y Rtn	-99.6%	42.3%	18.7%	37.7%	-	-	28.2%
1M Excs Rtn	-56.8%	-8.6%	-3.1%	-5.5%	-	-	-7.1%
3M Excs Rtn	-61.7%	-32.6%	-6.4%	-4.8%	-	-	-19.5%
6M Excs Rtn	-99.6%	-31.2%	-19.4%	-2.4%	-	-	-25.3%
12M Excs Rtn	-109.6%	-24.5%	-23.1%	-5.9%	-	-	-23.8%
3Y Excs Rtn	-162.0%	-24.2%	-49.5%	-27.7%	-	-	-38.6%

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021
Period End	6/30/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Filing Date	8/14/2025	3/31/2025	4/1/2024	3/23/2023	3/23/2023
Key Financials
Total Revenue	1	0	0	0	0
EBITDA	-7	-11	-15	-5	-4
Operating Income	-6	-5	-5	-6	-2
Net Income	-7	-10	-15	-9	-6
EPS	-8.78	-14.70	-43.80	-14.98	-10.58
Growth Rates
Total Revenue Growth	8438.7%	∞%	-	-	-
EBITDA Growth	54.1%	30.9%	-200.2%	-35.4%	-
Operating Income Growth	-15.2%	4.2%	5.3%	-183.9%	-
Net Income Growth	51.7%	32.9%	-70.6%	-39.7%	-
Margins
EBITDA Margin	-669.2%	-20870.2%	-	-	-
Operating Income Margin	-550.6%	-9933.8%	-	-	-
Net Income Margin	-683.0%	-20605.5%	-	-	-
Cash & Debt
Total Cash	2	0	3	0	0
Total Debt	0	1	2	4	10
Net Debt / (Cash)	-1	0	-1	4	10
Cash Flows
Net Cash from Operations	-4	-4	-8	-3	-1
Free Cash from Operations	-4	-4	-8	-3	-1
Returns to Shareholders
Dividends	0	-0	-0	-0	-0
Share Repurchases	-0	-0	-0	0	-0

$ Mil \| FY: 12/31	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3
Period End	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Filing Date	8/14/2025	5/15/2025	3/31/2025	11/14/2024	8/14/2024	5/15/2024	4/1/2024	11/15/2023	8/14/2023	5/15/2024	3/23/2023	11/15/2023
Key Financials Quarterly
Total Revenue	1	1	0	0	0	0	0	0	0	0	0	0
Ebitda	-2	-1	-1	-3	-3	-3	0	-9	-5	-2	-3	-5
Operating Income	-2	-2	-1	-1	-1	-1	-0	-2	-1	-1	-3	-1
Net Income	-2	-2	-1	-3	-3	-3	3	-11	-5	-2	-3	-6
EPS	-1.56	-1.52	-1.50	-4.20	-4.78	-4.28	4.10	-18.60	-8.77	-3.34	-5.34	-9.61
Key Financials TTM
Total Revenue TTM	1	1	0	0	0	0	0	0	0	0	-	-
Ebitda TTM	-7	-8	-11	-9	-15	-17	-15	-18	-14	-9	-	-
Operating Income TTM	-6	-5	-5	-4	-5	-5	-5	-8	-6	-5	-	-
Net Income TTM	-7	-9	-10	-6	-15	-17	-15	-22	-16	-11	-	-
Growth Rates Quarterly
Total Revenue Growth	3987.8%	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth	43.8%	58.9%	-1485.8%	67.5%	34.9%	-130.5%	102.6%	-91.3%	-1638.8%	-	-	-
Operating Income Growth	-56.0%	-9.2%	-202.4%	33.1%	19.9%	-8.3%	88.1%	-149.1%	-420.3%	-	-	-
Net Income Growth	42.9%	54.0%	-129.0%	74.9%	37.8%	-78.9%	201.4%	-89.0%	-1430.0%	-	-	-
Margins Quarterly
EBITDA Margin	-361.0%	-279.6%	-5523.8%	-13784.7%	-26273.7%	-	-	-	-	-	-	-
Operating Income Margin	-369.1%	-295.2%	-5760.5%	-6919.4%	-9671.2%	-	-	-	-	-	-	-
Net Income Margin	-374.6%	-295.1%	-5230.8%	-14028.4%	-26822.5%	-	-	-	-	-	-	-
Cash & Debt
Total Cash	2	1	0	1	2	1	3	8	0	-	0	-
Total Debt	0	1	1	1	1	2	2	10	0	0	4	0
Net Debt / (Cash)	-1	-0	0	-0	-1	1	-1	2	-0	-	4	-
Cash Flows Quarterly
FCF from Operations	-1	-1	-1	-1	-1	-1	-3	-4	-0	-0	-2	-1
Cash Flows TTM
FCF from Operations TTM	-4	-4	-4	-7	-10	-9	-8	-7	-4	-	-	-
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	-11.0%	-9.1%	-5.6%	-8.9%	-7.6%	-9.0%	-1.6%	-10.1%	-3.8%	-	-136.0%	-
Return on Invested Capital (ROIC) TTM
ROIC TTM	-8.5%	-7.6%	-7.7%	-6.8%	-8.1%	-8.7%	-6.3%	-9.1%	-4.0%	-	-	-

Price Behavior

Behavior Stats
Betas Matrix

Price Behavior

Market Price	$1.16
Market Cap ($ Bil)	0.0
First Trading Date	09/23/2021
Distance from 52W High	-94.4%
	50 Days	200 Days
DMA Price	$2.92	$7.76
DMA Trend	down	down
Distance from DMA	-60.2%	-85.0%
	3M	1YR
Volatility	279.9%	2,156.6%
Downside Capture	-145.76	219.69
Upside Capture	-426.99	-57.85
Correlation (SPY)	-8.4%	0.5%

XAGE Betas & Captures as of 8/31/2025

	1M	2M	3M	6M	1Y	3Y
Beta	-1.02	-5.17	-2.23	0.32	0.67	0.32
Up Beta	-1.29	-3.68	-0.13	-12.16	-8.46	-4.57
Down Beta	1.55	-6.30	-1.52	-0.55	0.46	-0.06
Up Capture	-218%	-208%	-161%	-10%	-6%	-3%
Bmk +ve Days	10	22	35	71	142	415
Stock +ve Days	9	17	22	45	93	278
Down Capture	-67%	-570%	-169%	150%	148%	106%
Bmk -ve Days	11	19	27	54	106	334
Stock -ve Days	12	22	37	76	149	336

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date	8292025
Short Interest: Shares Quantity	8,832
Short Interest: % Change Since 8152025	-42.6%
Average Daily Volume	19,780
Days-to-Cover Short Interest	1
Basic Shares Quantity	1,209,809
Short % of Basic Shares	0.7%

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
5/16/2025	18.3%	-20.7%	-24.3%
SUMMARY STATS
# Positive	1	0	0
# Negative	0	1	1
Median Positive	18.3%
Median Negative		-20.7%	-24.3%
Max Positive	18.3%
Max Negative		-20.7%	-24.3%

	Forward Returns
5/16/2025	18.3%	-20.7%	-24.3%
SUMMARY STATS
# Positive	1	0	0
# Negative	0	1	1
Median Positive	18.3%
Median Negative		-20.7%	-24.3%
Max Positive	18.3%
Max Negative		-20.7%	-24.3%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
6302025	8142025	10-Q 6/30/2025
3312025	5152025	10-Q 3/31/2025
12312024	3312025	10-K 12/31/2024
9302024	11142024	10-Q 9/30/2024
6302024	8142024	10-Q 6/30/2024
3312024	5152024	10-Q 3/31/2024
12312023	4012024	10-K 12/31/2023
9302023	11152023	10-Q 9/30/2023
6302023	8142023	10-Q 6/30/2023
12312022	3232023	S-4/A 12/31/2022

Insider Activity

Expand for More

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	Upton Richard A		9162024	Buy	0.47	5,000	2,336	7,008	Form
1	Gregory Kathryn		9102024	Buy	0.51	1,260	643	11,475	Form
2	Sturgeon Patrick A		9102024	Buy	0.51	1,261	643	9,206	Form
3	Cassaday Bryan J.	Chief Financial Officer	9102024	Buy	0.46	475	218	1,955	Form
4	Frisch Scott M.		9102024	Buy	0.51	1,009	515	3,875	Form

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Longevity Health (XAGE)

Market Price (9/17/2025): $2.29 | Market Cap: $2.8 MilSector: Consumer Staples | Industry: Household Products

Longevity Health (XAGE)

Market Price (9/17/2025): $2.29Market Cap: $2.8 MilSector: Consumer StaplesIndustry: Household Products

Investment Highlights

Market Valuation

Stock Price Chart

Market Cap Chart

Business Description

Price Returns Compared

Interactive Breakdown

Better Bets than Longevity Health (XAGE)

Latest Trefis Analyses

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Longevity Health

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (9/17/2025): $2.29 | Market Cap: $2.8 Mil
Sector: Consumer Staples | Industry: Household Products

Market Price (9/17/2025): $2.29
Market Cap: $2.8 Mil
Sector: Consumer Staples
Industry: Household Products